Regeneron Pharmaceuticals Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Regeneron Pharmaceuticals

REGN 674.95

+3.1%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: DewDiligence_on_SI who wrote (2921)	5/5/2020 7:57:39 AM
From: Miljenko Zuanic	Read Replies (1) of 3557

1Q-2020 report: investor.regeneron.com Eylea ROW 1Q as reported is $681.7M (v 653 based e 593m)! US Eylea sale ($1.172B) is even bit better than I expected, due to CoV2 (and beovu, beovu.com )! 2Q will be affected, Duki so far is OK (I continuously see DCA). Disappointment to me is...no live animal CoV2 pre-clinical info?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next